Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C
Abstract
Background Patients with chronic liver disease (CLD) and depression may be at a higher risk for various complications, including impaired quality of life and more advanced liver disease. The purpose of this study was to determine the prevalence of depression in CLD patients (non-alcoholic fatty liver disease (NAFLD), Hepatitis B (HBV), and Hepatitis C (HCV)) and to identify potential clinical and laboratory correlates of depression in these patients.Methods We used a database of CLD patients that contains extensive clinical (including self-reported depression) and laboratory data for each patient. We compared the prevalence of depression in patients with HBV, HCV, and NAFLD. We also used regression models to find independent predictors of depression in these patients.Results Of 878 CLD patients, 207 (23.6%) had a diagnosis of depression (NAFLD 27.2%, HCV 29.8%, and HBV 3.7%). Examination of predictors of depression differed by the type of chronic liver disease. For NAFLD, independent predictors of depression were the presence of hypertension, smoking, history of lung disease, being female, and non-African-American. For HBV patients, the only independent predictor of depression was excessive alcohol consumption (defined as >10 g/d), while for HCV patients, independent predictors were being female and non-Asian, presence of fatigue, and excessive alcohol intake.Conclusions This study demonstrates that individuals with NAFLD and HCV have a higher prevalence of depression than HBV patients and the rates of depression reported for the general population. The most consistent correlates of depression status in CLD patients are being female and excessive alcohol consumption.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Patients with NAFLD were shown to have a significantly higher prevalence of depression compared with those with hepatitis B (3.7%) but not hepatitis C (29.8%).
“Further, patients with NAFLD were shown to have a significantly higher prevalence of DEP compared with those with hepatitis B (HBV; 3.7%) but not hepatitis C (29.8%).[12]”
From Prevalence of depression and anxiety symptoms by liver disease etiology (2023) · cites this paper as [12]
Weinstein and colleagues reported the prevalence of depression to be 27.2% in NAFLD when using self-reported diagnoses paired with confirmatory medical record review.
“For example, Weinstein and colleagues reported the prevalence of DEP to be 27.2% in NAFLD when using self-reported diagnoses paired with confirmatory medical record review.”
From Prevalence of depression and anxiety symptoms by liver disease etiology (2023) · cites this paper as [12]
The prevalence of depression in patients with hepatitis B virus has been examined, though limited data on rates of anxiety are available.
“The prevalence of DEP in patients with HBV has been examined, [12,17,23,28,31,32] though limited data on rates of ANX are available.[17,28]”
From Prevalence of depression and anxiety symptoms by liver disease etiology (2023) · cites this paper as [12]
Comparative investigations commonly show that the prevalence of depression in patients with hepatitis B virus is lower than that in patients with hepatitis C virus, a finding that extends to both self-report-diagnosed and clinician-diagnosed depression.
“Comparative investigations commonly show that the prevalence of DEP in patients with HBV is lower than that in patients with HCV, [12,17,32] a finding that extends to both self-report-diagnosed and clinician-diagnosed DEP.”
From Prevalence of depression and anxiety symptoms by liver disease etiology (2023) · cites this paper as [12]
Cites
Quality-of-Life Impairment in Depressive and Anxiety Disorders
Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1171 · Cited by 914 · see citing works
A systematic review of the mortality of depression
Wulsin, L. R., Vaillant, G. E., & Wells, V. E. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199901000-00003 · Cited by 703 · see citing works
Impact of major depression on chronic medical illness
Katon, W., & Ciechanowski, P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00313-6 · Cited by 485 · see citing works
Kessler, R. C., Merikangas, K. R., & Wang, P. S. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091444 · Cited by 468 · see citing works
The impact of diagnosis of hepatitis C virus on quality of life
Rodger, A. J., Jolley, D., Thompson, S., Lanigan, A., & Crofts, N. (1999) · Hepatology · doi:10.1002/hep.510300504 · Cited by 298 · see citing works
Depression, fatigue, and functional disability in patients with chronic hepatitis C
Dwight, M. M., Kowdley, K. V., Russo, J. E., Ciechanowski, P. S., Larson, A. M., & Katon, W. J. (2000) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(00)00155-0 · Cited by 258 · see citing works
Patten, S. B., Williams, J. V. A., Lavorato, D. H., Modgill, G., Jetté, N., & Eliasziw, M. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.05.001 · Cited by 257 · see citing works
Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors
Golden, J., O'Dwyer, A. M., & Conroy, R. M. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.06.006 · Cited by 211 · see citing works
Asnis, G. M., & Garza, R. D. L. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000210099.36500.fe · Cited by 170 · see citing works
Cholestatic liver diseases and health-related quality of life
Younossi, Z., Kiwi, M. L., Boparai, N., Price, L., & Guyatt, G. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01774.x · Cited by 131 · see citing works
Self-citationDepression, Anxiety, and Nonalcoholic Steatohepatitis
Elwing, J. E., Lustman, P. J., Wang, H. L., & Clouse, R. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221276.17823.df · Cited by 126 · see citing works
Determinants of quality of life in chronic liver patients
Gutteling, J. J., de Man, R. A., van der Plas, S. M., Schalm, S. W., Busschbach, J. J. V., & Darlington, A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02934.x · Cited by 126 · see citing works
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C†
Leutscher, P. D. C., Lagging, M., Buhl, M. R., Pedersen, C., Norkrans, G., Langeland, N., Mørch, K., Färkkilä, M. A., Hjerrild, S., Hellstrand, K., et al. (2010) · Hepatology · doi:10.1002/hep.23699 · Cited by 97 · see citing works
Goulding, C., O’Connell, P. G., & Murray, F. E. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200105000-00008 · Cited by 89 · see citing works
Comorbidities associated with the increasing burden of hepatitis C infection
Basseri, B., Yamini, D., Chee, G. M., Enayati, P. D. P., Tran, T. T., & Poordad, F. F. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02235.x · Cited by 61 · see citing works
Haag, S., Senf, W., Häuser, W., Tagay, S., Grandt, D., Heuft, G., Gerken, G., Talley, N. J., & Holtmann, G. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03619.x · Cited by 53 · see citing works
Hepatitis C and Depressive Symptoms: Psychological and Social Factors Matter More Than Liver Injury
Wilson, M. P., Castillo, E. M., Batey, A., Sapyta, J. J., & Aronson, S. G. (2010) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.40.2.f · Cited by 28 · see citing works
Tobacco and other factors have a negative impact on quality of life in hepatitis C patients
Yamini, D., Basseri, B., Chee, G. M., Arakelyan, A., Enayati, P. J., Tran, T. T., & Poordad, F. F. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01361.x · Cited by 26 · see citing works
Psychological distress in patients with chronic, nonalcoholic, uncomplicated liver disease
DAVIS, H.-S., De‐Nour, A. K., Shouval, D., et al. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(97)00288-2 · Cited by 16 · see citing works
Spiegel, B. M. R., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005) · Hepatology · doi:10.1002/hep.20659 · Cited by 7 · see citing works
Self-citationNovel Treatment Strategies for Depression in Patients With Hepatitis C
Loftis, J. M., & Turner, E. H. (2010) · Psychosomatics · doi:10.1176/appi.psy.51.4.357 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149 · see citing works
Self-citationYoussef, N. A., Abdelmalek, M. F., Binks, M., Guy, C. D., Omenetti, A., Smith, A. D., Diehl, A. M. E., & Suzuki, A. (2013) · Liver International · doi:10.1111/liv.12165 · Cited by 182 · see citing works
Mullish, B. H., Kabir, M. S., Thursz, M. R., & Dhar, A. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12925 · Cited by 144 · see citing works
Soto-Angona, Ó., Anmella, G., Valdés-Florido, M. J., De Uribe-Viloria, N., Carvalho, A. F., Penninx, B. W. J. H., & Berk, M. (2020) · BMC Medicine · doi:10.1186/s12916-020-01713-8 · Cited by 122 · see citing works
Depression and chronic liver diseases: are there shared underlying mechanisms?
Huang, X., Liu, X., & Yu, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00134 · Cited by 121 · see citing works
Association of chronic liver disease with depression: A population-based study
Lee, K., Otgonsuren, M., Younoszai, Z., Mir, H. M., & Younossi, Z. M. (2013) · Psychosomatics · doi:10.1016/j.psym.2012.09.005 · Cited by 104 · see citing works
Self-citationTomeno, W., Kawashima, K., Yoneda, M., Saito, S., Ogawa, Y., Honda, Y., Kessoku, T., Imajo, K., Mawatari, H., Fujita, K., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12897 · Cited by 98 · see citing works
Xiao, J., Lim, L. K. E., Ng, C. H., Tan, D. J. H., Lim, W. H., Ho, C. S. H., Tan, E. X. X., Sanyal, A. J., & Muthiah, M. D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.691696 · Cited by 94 · see citing works
Major depression and suicide attempts in patients with liver disease in the United States
Le Strat, Y., Le Foll, B., & Dubertret, C. (2015) · Liver International · doi:10.1111/liv.12612 · Cited by 50 · see citing works
Non-alcoholic fatty liver disease and its association with depression in Korean General Population
Jung, J. Y., Park, S. K., Oh, C.-M., Chung, P.-W., & Ryoo, J.-H. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e199 · Cited by 51 · see citing works
Interaction mechanisms between major depressive disorder and non-alcoholic fatty liver disease
Shao, Q., Wu, Y., Ji, J., Xu, T., Yu, Q., Ma, C., Liao, X., Cheng, F., & Wang, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.711835 · Cited by 32 · see citing works
Management of psychiatric disorders in patients with hepatic and gastrointestinal diseases
Menon, V., Ransing, R., & Praharaj, S. K. (2022) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_18_22 · Cited by 19 · see citing works
Prevalence of depression and anxiety symptoms by liver disease etiology
Doyle, T., Schmidt, B., & Scaglione, S. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000068 · Cited by 6 · see citing works
Shea, S., Lionis, C., Kite, C., Atkinson, L., Chaggar, S. S., Randeva, H. S., & Kyrou, I. (2021) · Biomedicines · doi:10.3390/biomedicines9111697 · Cited by 4 · see citing works
- Authors
- Weinstein, A. A., Kallman Price, J., Stepanova, M., Poms, L. W., Fang, Y., Moon, J., Nader, F., & Younossi, Z. M.
- Affiliations
- Inova Health System (US)
- George Mason University (US)
- Corresponding author
- Younossi, Zobair M.
- Venue
- Psychosomatics
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 52
- Issue
- 2
- Pages
- 127-132
- ISSN
- 0033-3182 (ISSN-L)
- OpenAlex
- W2038382356
- Cited by
- 147
- References
- 21
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 11 · 2023: 10 · 2022: 19 · 2021: 13 · 2020: 15 · 2019: 9 · 2018: 14 · 2017: 5 · 2016: 4 · 2015: 9 · 2014: 9 · 2013: 13 · 2012: 4
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- depression, non-alcoholic fatty liver disease, chronic hepatitis B, chronic hepatitis C, chronic liver disease, depression prevalence, predictors of depression, alcohol consumption, sex differences, fatigue, hypertension, smoking
- MeSH terms
- Adult, Age Factors, Depression, Fatty Liver, Female, Humans, Male, Middle Aged, Quality of Life, Regression Analysis, Risk Factors, Sex Factors, Prevalence, Chi-Square Distribution, Statistics, Nonparametric, Hepatitis B, Chronic, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review